As tirzepatide is a relatively new medication whose side effect profile has yet to be fully characterized, clinicians should be aware of this rare yet potentially fatal complication. Although GLP-1 receptor agonists show impressive efficacy and favorable side effect profiles, it is necessary that we determine all risks and side effects, particularly rare ones, to minimize chances of poor outcomes, says the papers first author Eli J
APOE 4 and Alzheimers disease diagnosis associated differences in L-carnitine, GBB, TMAO and acylcarnitines in blood and brain
Neither risk is large with proper instruction, and both are manageable with a clear patient guide and provider support
those who did not (HR = 1.31
Additionally, several synthetic molecules were also tested
This medication mimics GLP-1 hormones to regulate blood sugar and appetite